Global Pharmacogenomics Market to reach a market size of $9.9 billion by 2025- KBV Research


Posted August 13, 2019 by kbv_research

The Global Pharmacogenomics Market size is expected to reach $9.9 billion by 2025, rising at a market growth of 8.8% CAGR during the forecast period.
 
According to a new report Global Pharmacogenomics Market, published by KBV research, The Global Pharmacogenomics Market size is expected to reach $9.9 billion by 2025, rising at a market growth of 8.8% CAGR during the forecast period.

The Hospitals and Clinics market dominated the Global Pharmacogenomics Market by End User in 2018, growing at a CAGR of 8.5 % during the forecast period. The Research Institutions market is expected to witness highest CAGR of 9.1% during (2019-2025).

The North America market dominated the Global Infectious Diseases Market by Region in 2018, growing at a CAGR of 9.1 % during the forecast period. The Europe market is expected to witness a CAGR of 9.3% during (2019-2025). Additionally, The Asia Pacific market is expected to witness a CAGR of 11.2% during (2019-2025).

The Sequencing market in the Global Pharmacogenomics Market by Technology would grow at a CAGR of 8 % during the forecast period. The Polymerase Chain Reaction market is expected to witness a CAGR of 8.1% during (2019-2025).

Full Report: https://www.kbvresearch.com/pharmacogenomics-market/

The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the globe with country wise analysis in each discussed region. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of Abbott Laboratories, Empire Genomics LLC, Illumina, Inc., oneome LLC, Myriad Genetics Inc., Thermo Fisher Scientific, Inc., Teva Pharmaceuticals Industries Ltd., Bayer AG, Opko Health, Inc., and Becton, Dickinson and Company.

Global Pharmacogenomics Market Segmentation

By Technology

Sequencing
Polymerase Chain Reaction
Electrophoresis
Mass Spectrometry
Microarray
Others

By Application

Oncology
Psychiatry
Infectious Diseases
Neurological Diseases
Pain management
Cardiovascular Diseases
Others

By End User

Hospitals and Clinics
Research Institutions
Academic Institutes

By Geography

North America

US
Canada
Mexico
Rest of North America

Europe

Germany
UK
France
Russia
Spain
Italy
Rest of Europe

Asia Pacific

China
Japan
India
South Korea
Singapore
Malaysia
Rest of Asia Pacific

LAMEA

Brazil
Argentina
UAE
Saudi Arabia
South Africa
Nigeria
Rest of LAMEA

Companies Profiled

Abbott Laboratories
Empire Genomics LLC
Illumina, Inc.
Oneome LLC
Myriad Genetics Inc.
Thermo Fisher Scientific, Inc.
Teva Pharmaceuticals Industries Ltd.
Bayer AG
Opko Health, Inc.
Becton, Dickinson and Company

Unique Offerings from KBV Research

Exhaustive coverage
Highest number of market tables and figures
Subscription based model available
Guaranteed best price
Assured post sales research support with 10% customization free

Pharmacogenomics Market Related Reports:

North America Market
Europe Market
Asia Pacific Market
LAMEA Market
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By KBV Research
Phone 6466616066
Business Address 244 Fifth Avenue, Suite 1407 New York, N.Y. 10001 United States (U.S)
Country United States
Categories Health
Tags kbv research , pharmacogenomics , pharmacogenomics market , pharmacogenomics market analysis , pharmacogenomics market growth , pharmacogenomics market size
Last Updated August 13, 2019